ReadYourDNA

Apixaban (Eliquis)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Apixaban

What it is

Apixaban is a direct oral anticoagulant (DOAC): it blocks factor Xa, a central clotting enzyme, so blood takes longer to clot. It does not need regular blood tests. It is used to lower the chance of stroke in atrial fibrillation, to prevent and treat clots in the legs and lungs, and after hip or knee replacement. It is sold as Eliquis.

How genes come into it

Apixaban is broken down mainly by CYP3A4, with help from CYP3A5, and pumped out of cells by ABCB1 and ABCG2; part is cleared by the kidneys. Studies have linked ABCG2 and CYP3A5 variants to modest differences in its blood levels, and ABCB1 to bleeding, with mixed results. No gene changes its effect the way VKORC1 changes warfarin's, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Apixaban. Upload your DNA file to see which of these rows apply to you.

Rated evidence (3 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

ABCG2 rs2231142: Level 3. Metabolism/PK: Atrial Fibrillation. 2.

CYP3A5 rs776746: Level 3. Metabolism/PK: Atrial Fibrillation. 2.

ABCB1 rs4148738: Level 3. Toxicity. 1.

Metabolism (20 findings)

Studies of how quickly the body processes this medication.

ABCB1 rs1045642: Genotype GG is associated with decreased concentrations of apixaban, dabigatran, edoxaban or rivaroxaban in people with Thromboembolism as compared to genotypes AA + AG.

ABCC2 rs2273697: Genotypes AA + AG is associated with increased half-life time of apixaban in healthy individuals as compared to genotype GG.

ABCG2 rs2231142: Genotype TT is associated with increased concentrations of apixaban in people with Atrial Fibrillation as compared to genotype GG.

ABCG2 rs2231142: Allele G is associated with decreased concentrations of apixaban in people with Atrial Fibrillation as compared to allele T.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Pradaxa (DOACs)

Savaysa (DOACs)

Xarelto (DOACs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com